+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rare Biomarkers Specimen Collection & Stabilization Market by Product, Specimen Type, Stabilization Technique, Collection Method, Application, End User - Global Forecast 2026-2032- Product Image
Rare Biomarkers Specimen Collection & Stabilization Market by Product, Specimen Type, Stabilization Technique, Collection Method, Application, End User - Global Forecast 2026-2032- Product Image
Sale

Rare Biomarkers Specimen Collection & Stabilization Market by Product, Specimen Type, Stabilization Technique, Collection Method, Application, End User - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012260
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Rare Biomarkers Specimen Collection & Stabilization Market is projected to reach USD 37.41 Billion in 2026. It is expected to continue growing at a CAGR of 8.00%, reaching USD 59.52 Billion by 2032.

Rare biomarker specimen collection and stabilization has become a critical infrastructure layer for precision medicine, oncology, neurology, immunology, infectious disease research, rare disease studies, and companion diagnostics. The value of a rare biomarker is often determined before the specimen reaches the analytical platform: blood draw technique, tube chemistry, processing time, temperature control, freeze-thaw exposure, hemolysis control, consent status, and chain-of-custody documentation can materially affect circulating tumor DNA, exosomes, circulating tumor cells, low-abundance proteins, metabolites, microbiome markers, and RNA signatures.

The sector is gaining strategic importance because clinical trials and diagnostics are moving toward smaller patient subgroups defined by molecular features. Evidence-based programs such as the U.S. FDA Biomarker Qualification Program, NIH All of Us Research Program, UK Biobank, the International Agency for Research on Cancer biobank resources, and large oncology sequencing initiatives have reinforced that high-quality biospecimens, standardized pre-analytical controls, and harmonized metadata are prerequisites for reproducible biomarker discovery, clinical validation, and regulatory acceptance.

Transformative Shifts in the Specimen Stabilization Landscape

The landscape is shifting from conventional sample handling toward integrated pre-analytical systems that preserve fragile analytes at the point of collection. Stabilization tubes, dried blood spot and microsampling devices, cryogenic workflows, automated aliquoting, mobile collection kits, and digital chain-of-custody platforms are being adopted to reduce variability and protect biomarkers that degrade rapidly after collection.

Another transformative shift is the movement from centralized, hospital-based sampling to hybrid and decentralized models. Home phlebotomy, remote clinical trials, direct-to-participant biobanking, and community-based specimen collection increase access to geographically dispersed and underrepresented populations, but they also raise the importance of validated ambient-temperature stabilization, standardized instructions, secure consent capture, and traceable logistics to maintain specimen integrity across longer transport routes.

Cumulative Impact of Artificial Intelligence on Specimen Quality

Artificial intelligence is increasingly used to improve specimen quality, not merely to analyze downstream omics data. AI-enabled laboratory information management systems can flag delayed processing, temperature excursions, hemolysis risk, insufficient volume, incorrect tube selection, missing consent fields, and chain-of-custody inconsistencies before low-abundance biomarker measurements are compromised.

In clinical research, machine learning supports protocol optimization by linking pre-analytical variables with assay performance, sample rejection patterns, and patient outcomes. The strongest near-term value is in quality prediction, anomaly detection, cohort enrichment, metadata harmonization, and audit-ready workflow monitoring, provided models are validated, explainable, protected against bias, and aligned with regulatory expectations for data integrity and clinical evidence.

Key Regional Insights Across Global Rare Biomarker Workflows

Asia-Pacific is advancing rapidly as China, Japan, South Korea, India, and Australia expand genomics, oncology testing, national biobank capacity, and precision medicine programs. Demand is supported by large patient populations, increasing clinical trial activity, broader use of next-generation sequencing, and rising adoption of liquid biopsy and molecular diagnostics. However, regional variability in cold-chain infrastructure, rural access, courier reliability, and laboratory standardization keeps validated stabilization technologies central to reliable rare biomarker research.

North America remains a leading region due to mature biopharma research, FDA-regulated biomarker and companion diagnostic pathways, CLIA-certified laboratory networks, extensive cancer center trial activity, and established biorepository practices. Europe benefits from the European Union’s research funding ecosystem, biobank networks, GDPR-driven data governance, ISO-aligned quality systems, and IVDR requirements that raise expectations for validated sample workflows. Latin America is building relevance through oncology modernization, infectious disease surveillance, and population-diverse clinical recruitment, while the Middle East is advancing precision medicine through national genomics programs, hospital modernization, and biobank investment. Africa’s opportunity is linked to genomic diversity, infectious disease research, and expanding laboratory networks, with specimen transport reliability, temperature control, ethical governance, and workforce training shaping adoption across the continent.

Key Group Insights for Strategic Market Prioritization

ASEAN markets are becoming more important for decentralized trials and population-diverse biomarker research as Singapore, Thailand, Malaysia, Vietnam, Indonesia, and the Philippines expand clinical research networks, digital health programs, and molecular diagnostic capacity. The GCC is investing in precision medicine and genomics, with national health strategies in Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman supporting advanced diagnostics, population genomics, and biobanking infrastructure where robust stabilization is essential for hot-climate logistics.

The European Union is a key regulatory and research anchor because GDPR, IVDR, Horizon Europe funding, cross-border biobank practices, and established ethics frameworks influence sample consent, traceability, interoperability, and analytical validation. BRICS countries provide scale, disease diversity, and genetic diversity for discovery programs, while the G7 leads in regulatory science, advanced laboratory automation, high-value clinical trials, and quality management standards. NATO-aligned countries add relevance through biodefense, infectious disease preparedness, emergency response, and resilient medical supply chains where stabilized specimens support surveillance, diagnostics readiness, and rapid evidence generation.

Key Country Insights for Clinical and Commercial Expansion

The United States leads in translational oncology, companion diagnostics, rare disease trials, and liquid biopsy adoption, supported by FDA guidance, NIH-funded research, academic cancer centers, and a dense network of reference laboratories. Canada contributes strong biobanking governance, population health research, and oncology collaboration, while Mexico is increasingly important for regional clinical recruitment and cross-border diagnostic access. Brazil adds scale through major academic hospitals, oncology research, infectious disease expertise, and genetically diverse cohorts that require consistent specimen stabilization to support reproducible biomarker analysis.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine advanced academic medical centers with regulated biobank, molecular pathology, and clinical trial ecosystems. Germany’s laboratory quality infrastructure, France’s national health research networks, the United Kingdom’s genomic medicine programs, Italy’s oncology centers, and Spain’s clinical research capacity support growing demand for validated pre-analytical workflows. Russia maintains scientific and clinical research capacity but faces constraints related to geopolitical conditions, logistics, and access to specialized supplies.

In Asia-Pacific, China is scaling genomics, oncology sequencing, and liquid biopsy research; India offers large and diverse patient cohorts with expanding molecular diagnostics; Japan provides advanced diagnostics, aging-population research, and high-quality laboratory practices; South Korea contributes automation, digital health integration, and strong clinical research infrastructure; and Australia contributes high-quality clinical trial operations, population biobanks, and standardized biospecimen governance.

Actionable Recommendations for Industry Leaders

Industry leaders should standardize pre-analytical variables across every collection site, including tube type, draw order, inversion count, time to centrifugation, processing temperature, storage duration, shipment conditions, acceptable temperature excursions, freeze-thaw limits, and documentation requirements. Using ISBER best practices, ISO 20387-aligned biobanking systems, CAP/CLIA quality expectations where applicable, and assay-specific validation helps reduce avoidable variability in rare biomarker measurement.

Organizations should also invest in digital sample tracking, real-time temperature monitoring, validated ambient stabilization for decentralized collection, automated aliquoting, electronic consent integration, and recurring staff training programs. Strategic partnerships among diagnostic developers, clinical research organizations, biobanks, logistics providers, healthcare systems, and academic centers can accelerate biomarker validation while preserving data integrity, patient consent, regulatory readiness, and cross-site reproducibility.

Research Methodology for Evidence-Based Market Analysis

This executive summary is grounded in secondary research from verified public sources, including regulatory guidance, peer-reviewed literature, standards organizations, biobank best-practice frameworks, clinical trial infrastructure reports, public health resources, and national precision medicine initiatives. The analysis prioritizes evidence from organizations such as the FDA, NIH, EMA, ISO, ISBER, OECD, WHO, IARC, and recognized public biobank and genomics programs.

The methodology evaluates industry dynamics through pre-analytical workflow requirements, biospecimen integrity risks, clinical research adoption, regulatory expectations, regional healthcare infrastructure, laboratory accreditation practices, data governance requirements, and technology readiness. Insights were synthesized to identify durable trends without relying on unverified claims, market-size statements, market-share rankings, or unsupported projections.

Conclusion: Stabilized Specimens Are the Foundation of Precision Medicine

Rare biomarker specimen collection and stabilization is now a strategic enabler of precision medicine rather than a back-office laboratory function. As biomarkers become rarer, more complex, and more clinically consequential, the integrity of the biospecimen will increasingly determine the reliability of discovery, validation, patient stratification, and diagnostic decision-making.

Organizations that combine validated stabilization technologies, standardized protocols, AI-supported quality control, resilient logistics, and compliant data governance will be best positioned to support next-generation diagnostics, decentralized trials, global biobanking, and more representative biomarker research.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Rare Biomarkers Specimen Collection & Stabilization Market, by Product
7.1. Blood Collection Tubes
7.2. Isolation Kits & Reagents
7.3. Systems
8. Rare Biomarkers Specimen Collection & Stabilization Market, by Specimen Type
8.1. ccfDNA
8.2. ccfRNA
8.3. CTCs
8.4. Exosomes/Extracellular Vesicles
9. Rare Biomarkers Specimen Collection & Stabilization Market, by Stabilization Technique
9.1. Chemical
9.2. Lyophilization
9.3. Temperature Control
9.3.1. Freezing
9.3.2. Refrigeration
10. Rare Biomarkers Specimen Collection & Stabilization Market, by Collection Method
10.1. Automated
10.2. Manual
11. Rare Biomarkers Specimen Collection & Stabilization Market, by Application
11.1. Genetic Testing
11.2. Infectious Disease
11.3. Neurology
11.4. Oncology
12. Rare Biomarkers Specimen Collection & Stabilization Market, by End User
12.1. Cros
12.2. Diagnostic Centers
12.3. Hospital Laboratories
12.4. Research Institutes
13. Asia-Pacific Rare Biomarkers Specimen Collection & Stabilization Market
14. North America Rare Biomarkers Specimen Collection & Stabilization Market
15. Latin America Rare Biomarkers Specimen Collection & Stabilization Market
16. Europe Rare Biomarkers Specimen Collection & Stabilization Market
17. Middle East Rare Biomarkers Specimen Collection & Stabilization Market
18. Africa Rare Biomarkers Specimen Collection & Stabilization Market
19. ASEAN Rare Biomarkers Specimen Collection & Stabilization Market
20. GCC Rare Biomarkers Specimen Collection & Stabilization Market
21. European Union Rare Biomarkers Specimen Collection & Stabilization Market
22. BRICS Rare Biomarkers Specimen Collection & Stabilization Market
23. G7 Rare Biomarkers Specimen Collection & Stabilization Market
24. NATO Rare Biomarkers Specimen Collection & Stabilization Market
25. United States Rare Biomarkers Specimen Collection & Stabilization Market
26. Canada Rare Biomarkers Specimen Collection & Stabilization Market
27. Mexico Rare Biomarkers Specimen Collection & Stabilization Market
28. Brazil Rare Biomarkers Specimen Collection & Stabilization Market
29. United Kingdom Rare Biomarkers Specimen Collection & Stabilization Market
30. Germany Rare Biomarkers Specimen Collection & Stabilization Market
31. France Rare Biomarkers Specimen Collection & Stabilization Market
32. Russia Rare Biomarkers Specimen Collection & Stabilization Market
33. Italy Rare Biomarkers Specimen Collection & Stabilization Market
34. Spain Rare Biomarkers Specimen Collection & Stabilization Market
35. China Rare Biomarkers Specimen Collection & Stabilization Market
36. India Rare Biomarkers Specimen Collection & Stabilization Market
37. Japan Rare Biomarkers Specimen Collection & Stabilization Market
38. Australia Rare Biomarkers Specimen Collection & Stabilization Market
39. South Korea Rare Biomarkers Specimen Collection & Stabilization Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Agena Bioscience
41.2. Agilent Technologies
41.3. ANGLE plc
41.4. Becton Dickinson (BD)
41.5. Bio-Rad Laboratories
41.6. Bio-Techne
41.7. Biomatrica
41.8. Charles River Laboratories
41.9. Crown Bioscience
41.10. DNA Genotek
41.11. Eurofins Scientific
41.12. F. Hoffmann-La Roche
41.13. GenTegra
41.14. Greiner Bio-One
41.15. iProcess Global Research
41.16. MagBio Genomics
41.17. Merck KGaA
41.18. Norgen Biotek
41.19. OraSure Technologies
41.20. PerkinElmer
41.21. PreAnalytiX
41.22. Precision for Medicine
41.23. QuartzBio
41.24. Siemens Healthineers
41.25. Thermo Fisher Scientific
List of Figures
FIGURE 1. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 15. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2025 VS 2032 (%)
FIGURE 21. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 25. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ISOLATION KITS & REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ISOLATION KITS & REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ISOLATION KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CCFDNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CCFDNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CCFDNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CCFRNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CCFRNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CCFRNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CTCS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CTCS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CTCS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL EXOSOMES/EXTRACELLULAR VESICLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL EXOSOMES/EXTRACELLULAR VESICLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL EXOSOMES/EXTRACELLULAR VESICLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CHEMICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CHEMICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CHEMICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL LYOPHILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL LYOPHILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL LYOPHILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL TEMPERATURE CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TEMPERATURE CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TEMPERATURE CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL FREEZING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL FREEZING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL FREEZING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL REFRIGERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL REFRIGERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL REFRIGERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MANUAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MANUAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MANUAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CROS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CROS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CROS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITAL LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 106. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 107. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 108. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 109. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 110. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 111. EUROPE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 122. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 123. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 124. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 125. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 126. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 130. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 131. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 132. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 133. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 134. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. ASEAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 138. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 139. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 140. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 141. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 142. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. GCC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 154. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 155. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 156. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 157. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 158. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. BRICS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 162. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 163. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 164. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 165. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 166. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. G7 RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 170. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 171. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 172. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 173. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 174. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. NATO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 186. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 187. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 188. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 189. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 190. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 193. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 194. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 195. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 196. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 197. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 198. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 201. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 202. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 203. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 204. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 205. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 206. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 210. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 211. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 212. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 213. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 214. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 217. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 218. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 219. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 220. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 221. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 222. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 223. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 225. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 226. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 227. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 228. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 229. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 230. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 234. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 235. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 236. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 237. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 238. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 241. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 242. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 243. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 244. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 245. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 246. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 249. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 250. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 251. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 252. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 253. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 254. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 257. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 258. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 259. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 260. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 261. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 262. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 263. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 264. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 265. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 266. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 267. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 268. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 269. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 270. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 271. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 273. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 274. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 275. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 276. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 277. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 278. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 279. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 281. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 282. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 283. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STABILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 284. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
TABLE 285. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION METHOD, 2018-2032 (USD MILLION)
TABLE 286. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. AUSTRALIA RARE BIOMARKERS

Companies Mentioned

The companies featured in this Rare Biomarkers Specimen Collection & Stabilization market report include:
  • Agena Bioscience
  • Agilent Technologies
  • ANGLE plc
  • Becton Dickinson (BD)
  • Bio-Rad Laboratories
  • Bio-Techne
  • Biomatrica
  • Charles River Laboratories
  • Crown Bioscience
  • DNA Genotek
  • Eurofins Scientific
  • F. Hoffmann-La Roche
  • GenTegra
  • Greiner Bio-One
  • iProcess Global Research
  • MagBio Genomics
  • Merck KGaA
  • Norgen Biotek
  • OraSure Technologies
  • PerkinElmer
  • PreAnalytiX
  • Precision for Medicine
  • QuartzBio
  • Siemens Healthineers
  • Thermo Fisher Scientific

Table Information

Report AttributeDetails
No. of Pages190
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 37.41 Billion
Forecasted Market Value ( USD ) by 2032 $ 59.52 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Rare Biomarkers Specimen Collection and Stabilization - Global Strategic Business Report - Product Image

Rare Biomarkers Specimen Collection and Stabilization - Global Strategic Business Report

  • Report
  • 132 Pages
  • Global
From
Rare Biomarkers Specimen Collection and Stabilization Market Report 2026 - Product Image

Rare Biomarkers Specimen Collection and Stabilization Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cancer Biomarkers Market by Biomarker Type, Technology, Cancer Type, Test Type, Application, End User - Global Forecast 2026-2032 - Product Image

Cancer Biomarkers Market by Biomarker Type, Technology, Cancer Type, Test Type, Application, End User - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Lung Cancer Liquid Biopsy Market Outlook 2026-2034: Market Share and Growth Analysis by Analyte / Biomarker (ctDNA, cfDNA, CTCs, Exosomes / Extracellular Vesicles / cfRNA, Methylation / Fragmentomics Signatures), Technology, Clinical Use Case, Cancer Subtype - Product Image

Lung Cancer Liquid Biopsy Market Outlook 2026-2034: Market Share and Growth Analysis by Analyte / Biomarker (ctDNA, cfDNA, CTCs, Exosomes / Extracellular Vesicles / cfRNA, Methylation / Fragmentomics Signatures), Technology, Clinical Use Case, Cancer Subtype

  • Report
  • 160 Pages
  • Global
From
Circulating Tumor Cells Global Market Insights 2026, Analysis and Forecast to 2031 - Product Image

Circulating Tumor Cells Global Market Insights 2026, Analysis and Forecast to 2031

  • Report
  • 89 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.